Last reviewed · How we verify

NCT06936072

Temporomandibular Joint Eminence Augmentation Using Titanium Ring Inlay: A New Surgical Technique

Completed NA Last updated 20 April 2025
What this trial tests

NA trial testing Titanium Ring Inlay Eminence Augmentation in TMJ in 112 participants. Completed in 3 April 2025.

Timeline
28 April 2024
Primary endpoint
3 April 2025
3 April 2025

Quick facts

Lead sponsorSinai University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment112
Start date28 April 2024
Primary completion3 April 2025
Estimated completion3 April 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sinai University

Who can join

Adults 25 to 41, any sex, with TMJ or Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the efficacy of titanium ring inlay in ESS technique in Temporomandibular joint eminence augmentation

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for TMJ

Currently open trials in the same condition.

Other Sinai University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06936072.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing